Q32 Bio Inc (QTTB) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Q32 Bio Inc

NASDAQ | QTTB

1.66

USD

0.00 ( 0.00%)

AT CLOSE (AS OF Jun 16, 2025)

$20M

MARKET CAP

P/E Ratio

-7.57

EPS

$54

52 Week High

$1.4

52 Week Low

LIFE SCIENCES

Sector

QTTB Chart

Recent Chart

Price Action

Candles

QTTB Technicals

Tags:

QTTB Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	-$487K
Total Revenue	$0
Cost Of Revenue	$487K
Costof Goods And Services Sold	$487K
Operating Income	-$66M
Selling General And Administrative	$18M
Research And Development	$48M
Operating Expenses	$66M
Investment Income Net	-
Net Interest Income	$2.8M
Interest Income	$3.9M
Interest Expense	$300K
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$487K
Income Before Tax	-$46M
Income Tax Expense	$21K
Interest And Debt Expense	-
Net Income From Continuing Operations	-$48M
Comprehensive Income Net Of Tax	-
Ebit	-$46M
Ebitda	-$45M
Net Income	-$48M

Revenue & Profitability

Earnings Performance

QTTB Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$92M
Total Current Assets	$82M
Cash And Cash Equivalents At Carrying Value	$78M
Cash And Short Term Investments	$78M
Inventory	-
Current Net Receivables	$555K
Total Non Current Assets	$10M
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	-
Intangible Assets Excluding Goodwill	-
Goodwill	-
Investments	-
Long Term Investments	$2.6M
Short Term Investments	-
Other Current Assets	$3.4M
Other Non Current Assets	-
Total Liabilities	$87M
Total Current Liabilities	$16M
Current Accounts Payable	$3M
Deferred Revenue	-
Current Debt	-
Short Term Debt	$3.7M
Total Non Current Liabilities	$70M
Capital Lease Obligations	$6.2M
Long Term Debt	$9.6M
Current Long Term Debt	$3.1M
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$19M
Other Current Liabilities	$9.8M
Other Non Current Liabilities	$55M
Total Shareholder Equity	$5.7M
Treasury Stock	-
Retained Earnings	-$235M
Common Stock	$2K
Common Stock Shares Outstanding	$9.7M

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	-$68M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$487K
Capital Expenditures	$75K
Change In Receivables	-
Change In Inventory	-
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	$95M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$48M

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	-$487K
Total Revenue	$0
Cost Of Revenue	$487K
Costof Goods And Services Sold	$487K
Operating Income	-$66M
Selling General And Administrative	$18M
Research And Development	$48M
Operating Expenses	$66M
Investment Income Net	-
Net Interest Income	$2.8M
Interest Income	$3.9M
Interest Expense	$300K
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$487K
Income Before Tax	-$46M
Income Tax Expense	$21K
Interest And Debt Expense	-
Net Income From Continuing Operations	-$48M
Comprehensive Income Net Of Tax	-
Ebit	-$46M
Ebitda	-$45M
Net Income	-$48M

QTTB News

QTTB Profile

Q32 Bio Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

None